Stock Information
Danaher Corp (DHR)
Ticker Symbol: DHR
Exchange: NYSE
Sector: Life Sciences Tools & Services
Market Cap: $134,997.53 mil
Piotroski score: 6
PE Ratio: 38.9293
EPS (TTM): 5.0518
Revenue (TTM): $34.57 M
Dividend Yield: 0.80559891244147%
ROE: 6.99%
Latest News
-
Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration
Wed, Apr 15, 2026 7:00 AM
-
Mar Vista U.S. Quality Premier Portfolio: Q1 2026 Leaders And Laggards
Wed, Apr 15, 2026 6:00 AM
-
Danaher (DHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Tue, Apr 14, 2026 2:00 PM
-
Goldman Sachs Maintains Buy on Danaher, Lowers Price Target to $230
Mon, Apr 13, 2026 2:00 PM
-
What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?
Mon, Apr 13, 2026 2:00 PM
-
Cell Therapy Technology Market Research and Global Forecast Report 2025-2030: Rising Chronic Disease Burden and CRISPR-Driven Gene Editing Innovations Driving Growth
Mon, Apr 13, 2026 10:11 AM
-
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes
Mon, Apr 13, 2026 7:01 AM
-
Danaher's Beckman Coulter And MeMed Bring CE-Marked Host-Response Testing To Core Labs With 20-Minute Bacterial Versus Viral Infection Differentiation Assay
Mon, Apr 13, 2026 4:09 AM
-
Masimo Buyout By Danaher Faces Shareholder Scrutiny On Deal Value
Sat, Apr 11, 2026 9:12 AM
-
Assessing Danaher (DHR) Valuation After Recent Share Price Weakness And Undervalued Fair Value Estimate
Thu, Apr 9, 2026 2:12 PM
Key Financials
Financial data not available